Research Shows 64% Antibiotics Sold In India Unapproved

The British Journal of Clinical Pharmacy has published the report about the regulatory approval status and sales volumes of systemic antibiotics marketed in India.

A research conducted by Queen Mary University of London and Newcastle University revealed that multinational companies produced and sold unregulated antibiotics in India on a large scale.

The Results are alarming:-

Of 118 systemic antibiotic FDC formulations marketed in India,

  • 43(36%) were approved
  • 75 (64%) had no record of regulatory approval;
  • 5(4%) formulations were approved in the UK and/or US.

For further details read here